Physician profile
Jason Brignac
NPI 1154935146
$1,482.39
in general payments reported to CMS, 2019-2025
24 companies · $934 in 2025
The $934 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $457 · 2022: $75.13 · 2024: $15.80 · 2025: $934.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $760 · Education: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $760.14 |
| Education | $189.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $382.01 | 2025 | Carvykti, Rybrevant, Erleada |
| Sumitomo Pharma America, INC. | $143.59 | 2025 | Gemtesa |
| Astellas Pharma US INC | $121.76 | 2025 | Xtandi |
| Abbvie INC. | $109.85 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $109.61 | 2021-2022 | |
| Antares Pharma, INC. | $98.68 | 2021-2025 | Xyosted |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $50.96 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $44.94 | 2025 | Provenge |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.93 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $38.08 | 2021 | |
| Teleflex LLC | $36.41 | 2025 | Urolift |
| Glaxosmithkline, LLC. | $35.86 | 2021 | |
| Sanofi-Aventis U.S. LLC | $28.80 | 2021-2022 | |
| Lilly USA, LLC | $28.58 | 2021 | |
| Ferring Pharmaceuticals INC. | $28.57 | 2025 | Adstiladrin |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $28.08 | 2021 | |
| Esperion Therapeutics, INC. | $26.01 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $24.64 | 2021 | |
| Endo USA, INC. | $22.62 | 2025 | Xiaflex |
| Boston Scientific Corporation | $17.39 | 2025 | Bulkamid |
| Procept Biorobotics Corporation | $17.32 | 2025 | |
| Dexcom, INC. | $16.75 | 2021 | |
| Exact Sciences Corporation | $15.80 | 2024 | Cologuard Collection Kit |
| Jazz Pharmaceuticals INC. | $15.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Brignac listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.